Sage Therapeutics Inc
NASDAQ:SAGE 3:59:55 PM EDT
| Market Cap (Intraday) | 2.25B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $39.89 |
| 50-Day MA | $39.38 |
| 200-Day MA | $36.92 |
Sage Therapeutics Inc Stock, NASDAQ:SAGE
215 1st Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.299.8380
Number of Employees: 471
Description
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders of the brain with three key focus areas: depression, neurology, and neuropsychiatry. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.